Skip to main content

Table 3 Attitude of the hospital pharmacists concerning pharmacovigilance

From: Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study

Questions n (%) 95% CI
1. Which of the following health care professionals is/are responsible for ADRs reporting in your hospital?
a. Doctor 250 (86.5) 0.82–0.90
b. Pharmacist 289 (100) 1
c. Nurses 230 (79.6) 0.74–0.84
2. Do you support “direct ADR reporting” by the patient instead of health care professionals?
a. Yes 270 (93.4) 0.94–0.98
b. No 19 (6.6) 0.04–0.10
3. Do you think that ADR reporting and monitoring systems would benefit the patient?
a. Yes 289 (100) 1
b. No 0
4. Do you think pharmacists are the ones to assist physicians in ADR reporting?
a. Yes 289 (100) 1
b. No 0
5. Do you worry about legal problems while you think of ADR?
a. Yes 91 (31.5) 0.26–0.37
b. No 198 (68.5) 0.63–0.74
6. Do you feel that ADR reporting is a time-consuming activity with no outcome?
a. Yes 91 (31.5) 0.26–0.37
b. No 198 (68.5) 0.63–0.74
7. Do you think reporting is a professional obligation to you?
a. Yes 120 (41.5) 0.36–0.47
b. No 10 (3.5) 0.02–0.06
c. Don’t know 80 (27.7) 0.23–0.33
d. Perhaps 79 (27.3) 0.22–0.33
8. Do you believe reporting should be made mandatory for practicing pharmacists?
a. Yes 200 (69.2) 0.63–0.74
b. No 79 (27.3) 0.22–0.33
c. Don’t know 10 (3.5) 0.02–0.06
9. Are you interested in participating in an ADR reposting system?
a. Yes 280 (96.9) 0.94–0.99
b. No 9 (3.1) 0.01–0.06
10. Do you think there should be a National Pharmacovigilance Program?
a. Yes 289 (100) 1
b. No 0
11. If a National Pharmacovigilance Program is instituted, what is your expectation from it?
a. Someone from the center to coordinate with you. 273 (94.5) 0.91–0.97
b. Financial compensation for time and energy spent. 16 (5.5) 0.03–0.09
12. ADR reporting is important in order to: (check all that apply)
a. Enable safe drugs to be used. 289 (100) 1
b. Measure the incidence of ADRs. 270 (93.4) 0.90–0.96
c. Identify previously unrecognized ADRs. 270 (93.4) 0.90–0.96
d. Identify factors that might predispose to an ADR. 270 (93.4) 0.90–0.96
e. Compare ADRs for drugs in similar therapeutic classes. 221 (76.5) 0.71–0.81
f. Compare ADRs of the same drug from different drug companies. 221 (76.5) 0.71–0.81
13. In your opinion, pharmacist is encouraged to report ADRs when? (check all that apply)
a. The reaction is of a serious nature 289 (100) 1
b. The reaction is unusual 240 (83) 0.78–0.87
c. The reaction is to a new product 240 (83) 0.78–0.87
d. The reaction is not reported before a particular drug 240 (83) 0.78–0.87
e. The reaction is well recognized for a particular drug 159 (55) 0.49–0.61
14. In your opinion, pharmacists may be discouraged to report ADRs when: (check all that apply)
a. Level of clinical knowledge makes it difficult to decide whether or not an ADR has occurred 18 (6.2) 0.03–0.10
b. Uncertain Association Between the drug and the adverse reaction 7 (2.4) 0.01–0.05
c. The ADR is too trivial to report 3 (1) 0.01–0.03
d. Concern that a report will generate extra work 3 (1) 0.01–0.03
e. ADR reporting form is not available when needed 2 (0.7) 0.01–0.02
f. Not Enough Information Available from the patient 280 (96.9) 0.94–0.99
g. Lack of time to fill in a report 230 (79.6) 0.74–0.84
h. Did not know how to report 17 (5.9) 0.03–0.09
i. Unaware of the need to report an ADR 280 (96.9) 0.94–0.99
j. Consider if the doctors’ responsibility 2 (0.7) 0.01–0.02
k. Fear of legal liability 0
15. The perception of a safety culture revolves around which of the following statements:
a. Why waste our time on safety 0
b. We Do Something When We Have an incident 135 (46.7) 0.41–0.43
c. We have systems in place to manage all identified risks 6 (2.1) 0.01–0.04
d. We are always on the alert for risks that might emerge 7 (2.4) 0.01–0.05
e. Risk management is an integral part of everything that we do 141 (48.8) 0.43–0.55